Nonparametric estimation of population characteristics of the kinetics of lithium from observational and experimental data: individualization of chronic dosing regimen using a new Bayesian approach.

Abstract:

:A population analysis of the kinetics of lithium was performed from experimental and observational data in 113 subjects in order to propose a new approach for lithium dosage individualization. The kinetics of lithium is described by a two-compartment model. Age, body weight, height, and serum creatinine are included as covariates. Population analysis was performed by the nonparametric maximum likelihood method, which provides an estimate of the distribution of the five kinetic parameters and covariates. Mean lithium clearance was 1.50 L/h with a coefficient of variation (CV) of 38%, and was found to increase with body weight. Results were consistent with those of earlier studies and confirm a large interindividual variability. Data from a separate group of 35 patients were used to validate results: the estimated a priori and on covariate conditional distributions of the measured 24-h serum lithium concentration following a single dose were consistent with the corresponding measurements. A Bayesian approach for individualizing dosing schemes is proposed. This approach is based on minimization of a risk function expressing the deviation of the trough concentration at steady-state from the therapeutic range.

journal_name

Ther Drug Monit

authors

Taright N,Mentré F,Mallet A,Jouvent R

doi

10.1097/00007691-199406000-00006

subject

Has Abstract

pub_date

1994-06-01 00:00:00

pages

258-69

issue

3

eissn

0163-4356

issn

1536-3694

journal_volume

16

pub_type

杂志文章
  • In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia.

    abstract:BACKGROUND:Cytochrome P450 3A (CYP3A) isoenzyme metabolic activity varies between individuals and is therefore a possible candidate of influence on the therapeutic outcome of the tyrosine kinase inhibitor imatinib in patients with chronic myeloid leukemia (CML). The aim of this study was to investigate the influence of...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000268

    authors: Skoglund K,Richter J,Olsson-Strömberg U,Bergquist J,Aluthgedara W,Ubhayasekera SJ,Vikingsson S,Svedberg A,Söderlund S,Sandstedt A,Johnsson A,Aagesen J,Alsenhed J,Hägg S,Peterson C,Lotfi K,Gréen H

    更新日期:2016-04-01 00:00:00

  • Highly specific quantification of ergotamine in urine, blood, and hair samples by liquid chromatography-tandem mass spectrometry.

    abstract::Ergotamine has been used for therapeutic purposes since the 1950s, usually to treat vascular headache. It is highly toxic and in large, repeated doses can produce all the symptoms of ergot poisoning. A selective and sensitive method, based on liquid chromatography-tandem mass spectrometry (LC-MS2), has been developed ...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/FTD.0b013e318067dfe7

    authors: Favretto D,Frison G,Vogliardi S,Ferrara SD

    更新日期:2007-06-01 00:00:00

  • External evaluation of population pharmacokinetics and pharmacodynamics in linezolid-induced thrombocytopenia: the transferability of published models to different hospitalized patients.

    abstract:OBJECTIVES:The objective of the present study was to perform an external evaluation of published linezolid population pharmacokinetic and pharmacodynamic models, in order to evaluate the predictive performance using an independent dataset. Another aim was to offer an elegant environment for display and simulation of bo...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000816

    authors: Ogami C,Tsuji Y,Nishi Y,Kawasuji H,To H,Yamamoto Y

    更新日期:2020-09-28 00:00:00

  • Quantification of Serum Sulfamethoxazole and Trimethoprim by Ultra-fast Solid-Phase Extraction-Tandem Mass Spectrometry.

    abstract:BACKGROUND:The combination of trimethoprim (TMP) and sulfamethoxazole (SMX) is used to treat a number of bacterial infections. TMP/SMX concentrations in serum are conventionally monitored using high-performance liquid chromatography (HPLC) or liquid chromatography tandem mass spectrometry. These methods require laborio...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000785

    authors: Fatica E,Faber J,Gaffron C,Bjergum M,Langman L,Jannetto P

    更新日期:2020-10-01 00:00:00

  • Stability of FK 506 in whole blood samples.

    abstract::The effect of storage time and temperature on the stability of FK 506 in patient blood samples and quality control samples was assessed with the Abbott IMx microparticle enzyme immunoassay. Blood FK 506 concentrations measured at days 0, 2, 3, 4, 7, and 14 were stable at room (22 degrees C), refrigerator (4 degrees C)...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199506000-00009

    authors: Freeman DJ,Stawecki M,Howson B

    更新日期:1995-06-01 00:00:00

  • Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studies.

    abstract::A comparative bioavailability study of carbamazepine (CBZ) in tablets and a syrup preparation was carried out in six volunteers, using a crossover design. Plasma and saliva samples were collected at appropriate times, and the plasma specimens were analyzed by high performance liquid chromatography for concentrations o...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198503000-00005

    authors: Hooper WD,King AR,Patterson M,Dickinson RG,Eadie MJ

    更新日期:1985-01-01 00:00:00

  • Quetiapine serum concentrations in psychiatric patients: the influence of comedication.

    abstract::Steady-state serum concentrations of quetiapine were recorded in 62 psychiatric patients under routine conditions. Doses were administered twice daily, and serum quetiapine levels were measured in the morning about 12 hours after the last dose. Eight patients were in monotherapy, whereas the rest received various addi...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/00007691-200410000-00005

    authors: Hasselstrøm J,Linnet K

    更新日期:2004-10-01 00:00:00

  • Effect of new Vacutainer blood collection tubes on plasma lidocaine concentrations.

    abstract::This study was designed to establish whether plasma lidocaine concentrations changed subsequent to contact with a new formulation of rubber-stopper Vacutainer collection tubes. Plasma lidocaine concentrations from blood samples exposed to rubber stoppers for one hour were compared with concentrations from blood sample...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198712000-00013

    authors: Lopez LM,Sen A,Robinson JD,Curry RW Jr

    更新日期:1987-12-01 00:00:00

  • Pharmacokinetics of high-dose oral and intravenous dexamethasone.

    abstract::Pharmacokinetics of intravenous and oral pulsed high-dose dexamethasone were studied in four patients with pemphigus vulgaris. Doses for dexamethasone were varied from 100 to 300 mg. Serum concentrations were measured by high-performance liquid chromatographic procedure with diode assay detection. Bioavailability was ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-199910000-00007

    authors: Tóth GG,Kloosterman C,Uges DR,Jonkman MF

    更新日期:1999-10-01 00:00:00

  • Fluconazole bioequivalence study: quantification by tandem mass spectrometry.

    abstract::To develop a new method for quantifying fluoconazole in human plasma and to compare the bioavailability of two fluconazole capsule formulations, an open, randomized, two-period crossover study with a one-week washout interval was conducted in 24 healthy volunteers. Plasma samples were obtained up to 168 hours after dr...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1097/00007691-199904000-00010

    authors: Moraes LA,Lerner FE,Moraes ME,Moraes MO,Corso G,De Nucci G

    更新日期:1999-04-01 00:00:00

  • Evaluation of cross-reactivity of urinary digoxin-like substance in different radioimmunoassays.

    abstract::For the accuracy of routine monitoring of digoxin and digitoxin it seems important to get information on the cross-reactivity of endogenous digitalis-like substances (EDLS). To obtain EDLS, urine was passed on Sep-Pak columns and eluted in fractions by increasing concentrations of acetonitrile. Dilution series of two ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:

    authors: Vinge E,Ekman R

    更新日期:1988-01-01 00:00:00

  • Clonazepam disposition in pediatric patients.

    abstract::Plasma clonazepam (CZP) and its metabolite [7-aminoclonazepam (7ACZP) and 7-acetamidoclonazepam (7AACZP)] concentrations were measured during a single dosing interval in 10 pediatric epilepsy patients (2-18 years, 11-102 kg) who had been receiving CZP therapeutically from 2 weeks to 4 years. These concentrations were ...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/00007691-199602000-00001

    authors: Walson PD,Edge JH

    更新日期:1996-02-01 00:00:00

  • Valproic acid binding to human serum and human placenta in vitro.

    abstract::The binding characteristics of the antiepileptic agent and teratogen valproic acid for human serum and human placenta were investigated utilizing equilibrium dialysis of the drugs in serum and in homogenates of whole placenta so that the transplacental transfer of the drug could be better defined. A low-capacity, high...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/01.ftd.0000158077.07836.9a

    authors: Bailey DN,Briggs JR

    更新日期:2005-06-01 00:00:00

  • Limited sampling strategies for therapeutic drug monitoring of mycophenolate mofetil therapy in patients with autoimmune disease.

    abstract::Mycophenolate mofetil (MMF) is increasingly used for the treatment of autoimmune diseases (AID). In renal transplant recipients, it has been demonstrated that adjustment of the MMF dose according to the area under the plasma concentration versus time curve (AUC) of mycophenolic acid (MPA), the active moiety of MMF, im...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0b013e3181a23f1a

    authors: de Winter BC,Neumann I,van Hest RM,van Gelder T,Mathot RA

    更新日期:2009-06-01 00:00:00

  • P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphism.

    abstract::The aim of the current study was to compare the pharmacokinetics of phenobarbital (PB) in extensive metabolizers (EMs) and poor metabolizers (PMs) of S-mephenytoin. Ten healthy volunteers (5 EMs and 5 PMs) were given 30 mg PB daily for 14 days. PB and p-hydroxyphenobarbital (p-OHPB) in serum and urine were measured by...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/00007691-200104000-00004

    authors: Hadama A,Ieiri I,Morita T,Kimura M,Urae A,Irie S,Kaneda T,Mamiya K,Tashiro N,Higuchi S,Otsubo K

    更新日期:2001-04-01 00:00:00

  • Evaluation of caffeine as an in vivo probe for CYP1A2 using measurements in plasma, saliva, and urine.

    abstract::Twenty-five healthy volunteers were given 100 mg caffeine orally and several estimates of cytochrome P450 1A2 (CYP1A2) activity were evaluated. The validation was performed by correlation of different parameters in plasma, saliva, and urine to two measures of caffeine clearance, CL(oral) and CL(137X-->17X) that served...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-200008000-00008

    authors: Carrillo JA,Christensen M,Ramos SI,Alm C,Dahl ML,Benitez J,Bertilsson L

    更新日期:2000-08-01 00:00:00

  • Dasatinib, a multikinase inhibitor: therapy, safety, and appropriate management of adverse events.

    abstract::Tyrosine kinase inhibitors are the standard of care for the treatment of chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib is a second-generation tyrosine kinase inhibitor that has been shown to be efficacious in treatment of patients with chronic myeloid leukemia or ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章,评审

    doi:10.1097/FTD.0b013e3181f4d9c5

    authors: Shayani S

    更新日期:2010-12-01 00:00:00

  • A Validated Method for Quantification of Dolutegravir Using Ultra Performance Liquid Chromatography Coupled With UV Detection.

    abstract:BACKGROUND:Dolutegravir (DTG) is an integrase strand transfer inhibitor, which is a newly approved antiretroviral drug used for the treatment of HIV-infected naive and experienced individuals. Many aspects of DTG pharmacology remain to be studied. Our aim was to develop and fully validate a robust analytical method for...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000286

    authors: Wang X,Penchala SD,Amara A,Else L,McClure M,Boffito M

    更新日期:2016-06-01 00:00:00

  • A sensitive gas chromatographic assay for amitriptyline and nortriptyline in plasma.

    abstract::A method for the quantitative determination of the tricyclic antidepressant drug amitriptyline (AT) and its active major metabolite, nortriptyline (NT), in plasma is described. The method involves a three-step extraction procedure, no derivatization, and a rapid run on a gas--liquid chromatograph equipped with a nitro...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198212000-00006

    authors: Hals PA,Lundgren TI,Aarbakke J

    更新日期:1982-01-01 00:00:00

  • Serial free and plasma valproic acid and phenytoin monitoring and drug interactions.

    abstract::In 12 institutionalized epilepsy patients who had been treated 19 months (SD +/- 5) with valproic acid, 27.0 mg/kg (SD +/- 11.9), phenytoin, 6.33 mg/kg (SD +/- 1.36), and co-anticonvulsants, the mean percentage of daily free valproic acid was 11.72 (SD +/- 2.10) and of phenytoin 20.39 (SD +/- 3.32). By serial within-d...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198103000-00013

    authors: Haidukewych D,Rodin EA

    更新日期:1981-01-01 00:00:00

  • Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum.

    abstract::This investigation was designed to compare three assay techniques, the traditional bioassay (agar diffusion), and two more recent techniques, high-performance liquid chromatography (HPLC) and fluorescence polarization immunoassay (FPIA), for the determination of vancomycin concentrations in serum. One hundred clinical...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198406000-00019

    authors: Ristuccia PA,Ristuccia AM,Bidanset JH,Cunha BA

    更新日期:1984-01-01 00:00:00

  • Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevi

    abstract::Several studies suggest that therapeutic drug monitoring of protease inhibitors and nonnucleoside reverse transcriptase inhibitors may contribute to the clinical outcome of HIV-infected patients. Because of the growing number of antiretroviral drugs and of drug combinations than can be administered to these patients, ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/01.ftd.0000152680.36517.5d

    authors: Poirier JM,Robidou P,Jaillon P

    更新日期:2005-04-01 00:00:00

  • Therapeutic Drug Monitoring for Perampanel in Japanese Epilepsy Patients: Influence of Concomitant Antiepileptic Drugs.

    abstract:BACKGROUND:Perampanel is a new antiepileptic drug (AED) that acts as a noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptor antagonist and is mainly metabolized by cytochrome P450 (CYP) 3A4. This study evaluated the influence of concomitant AEDs on the serum concentration profile of pera...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000416

    authors: Yamamoto Y,Usui N,Nishida T,Takahashi Y,Imai K,Kagawa Y,Inoue Y

    更新日期:2017-08-01 00:00:00

  • Sorption of thiotepa to polyurethane catheter causes falsely elevated plasma levels.

    abstract::Central venous access catheters are commonly used in clinical oncology. The double lumen variant is applied in pharmacokinetic studies for simultaneous administration and blood sampling when frequent blood collections are necessary. Occlusion of one lumen, a common complication, necessitates the investigator perform b...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-200306000-00002

    authors: de Jonge ME,Mathôt RA,van Dam SM,Rodenhuis S,Beijnen JH

    更新日期:2003-06-01 00:00:00

  • Serum concentrations and side effects in psychiatric patients during risperidone therapy.

    abstract::Steady state serum concentrations of risperidone and 9-hydroxyrisperidone (9-OH-risperidone), the active moiety, were measured in 42 patients. The concentration-to-dose ratios (C/D) varied by a factor of 20, from 1.8 to 36.8 (nmol/l)/(mg/24 hours), and 90% of the active moiety was constituted of 9-OH-risperidone. No c...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/00007691-199808000-00004

    authors: Olesen OV,Licht RW,Thomsen E,Bruun T,Viftrup JE,Linnet K

    更新日期:1998-08-01 00:00:00

  • Relationships among nortriptyline, 10-OH(E)nortriptyline, and 10-OH(Z)nortriptyline steady-state plasma levels and nortriptyline dosage.

    abstract::The postulated therapeutic activity of nortriptyline metabolites has prompted investigation of dosage adjustments based on plasma levels of nortriptyline (NT) and its metabolites. The method assumes that metabolite concentrations vary independently of nortriptyline concentrations among patients. This study tests that ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/00007691-198905000-00001

    authors: Lukey BJ,Jones DR,Wright JH,Hurst HE

    更新日期:1989-01-01 00:00:00

  • A population pharmacokinetic-metabolism model for individualizing ciprofloxacin therapy in ophthalmology.

    abstract::The purpose of this study was to construct a population pharmacokinetic (PK) metabolism (MB) model to describe ciprofloxacin (C) concentrations in plasma and vitreous and aqueous humors in 26 patients. Ciprofloxacin was given as a 3-day oral prophylactic treatment to 26 patients before vitrectomy. Plasma, vitreous, an...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章

    doi:10.1097/00007691-200408000-00010

    authors: Di Marco MP,Chen J,Wainer IW,Ducharme MP

    更新日期:2004-08-01 00:00:00

  • Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring.

    abstract::Trough levels (TL) of cyclosporine (CS) measured in serum by the polyclonal radioimmunoassay (SR) are useful for dissecting the etiology of clinical events, but they are a poor guide to dosage adjustments. In renal transplant patients immunosuppressed by low doses of prednisone and CS given orally, once-a-day TL (24-h...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:

    authors: Grevel J,Welsh MS,Kahan BD

    更新日期:1989-01-01 00:00:00

  • Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose (C2).

    abstract::With the introduction of a cyclosporin monitoring strategy based on the use of a sample collected 2 hours after dosing (C2) rather than the predose sample (C0), there was concern that the differences in blood cyclosporin results from the various assay systems would result in assay-specific target ranges for C2 monitor...

    journal_title:Therapeutic drug monitoring

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1097/00007691-200304000-00005

    authors: Johnston A,Chusney G,Schütz E,Oellerich M,Lee TD,Holt DW

    更新日期:2003-04-01 00:00:00

  • Subtherapeutic Linezolid Concentration in a Patient With Bullous Pemphigoid Complicated by Methicillin-Resistant Staphylococcus aureus Infection: A Case Study.

    abstract::We presented a case of subtherapeutic linezolid concentration in a patient with bullous pemphigoid characterized by large area skin anabrosis complicated by methicillin-resistant Staphylococcus aureus infections. ...

    journal_title:Therapeutic drug monitoring

    pub_type: 杂志文章

    doi:10.1097/FTD.0000000000000758

    authors: Chen C,Zhang M,Chen H,Fang J

    更新日期:2020-08-01 00:00:00